Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteolytic processing of ErbB4 in breast cancer.
Hollmén M, Liu P, Kurppa K, Wildiers H, Reinvall I, Vandorpe T, Smeets A, Deraedt K, Vahlberg T, Joensuu H, Leahy DJ, Schöffski P, Elenius K. Hollmén M, et al. Among authors: joensuu h. PLoS One. 2012;7(6):e39413. doi: 10.1371/journal.pone.0039413. Epub 2012 Jun 22. PLoS One. 2012. PMID: 22761786 Free PMC article.
Association of Wwox with ErbB4 in breast cancer.
Aqeilan RI, Donati V, Gaudio E, Nicoloso MS, Sundvall M, Korhonen A, Lundin J, Isola J, Sudol M, Joensuu H, Croce CM, Elenius K. Aqeilan RI, et al. Among authors: joensuu h. Cancer Res. 2007 Oct 1;67(19):9330-6. doi: 10.1158/0008-5472.CAN-07-2147. Cancer Res. 2007. PMID: 17909041
Taxanes and anthracyclines in early breast cancer: which first?
Wildiers H, Forceville K, Paridaens R, Joensuu H. Wildiers H, et al. Among authors: joensuu h. Lancet Oncol. 2010 Mar;11(3):219-20. doi: 10.1016/S1470-2045(10)70025-5. Lancet Oncol. 2010. PMID: 20202604 No abstract available.
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.
Joensuu H, Fraser J, Wildiers H, Huovinen R, Auvinen P, Utriainen M, Nyandoto P, Villman KK, Halonen P, Granstam-Björneklett H, Lundgren L, Sailas L, Turpeenniemi-Hujanen T, Tanner M, Yachnin J, Ritchie D, Johansson O, Huttunen T, Neven P, Canney P, Harvey VJ, Kellokumpu-Lehtinen PL, Lindman H. Joensuu H, et al. JAMA Oncol. 2018 Sep 1;4(9):1199-1206. doi: 10.1001/jamaoncol.2018.1380. JAMA Oncol. 2018. PMID: 29852043 Free PMC article. Clinical Trial.
Factors predicting late mortality from breast cancer.
Toikkanen SP, Kujari HP, Joensuu H. Toikkanen SP, et al. Among authors: joensuu h. Eur J Cancer. 1991;27(5):586-91. doi: 10.1016/0277-5379(91)90224-2. Eur J Cancer. 1991. PMID: 1828967
611 results